The discussion of t(1;17)(p11;q21) translocation in acute promyelocytic leukemia patient on molecular remission.

Some chromosomal aberrations emerging in the course of treatment are probably not related to disease progression, but attribute to the germline alteration. Therefore, the dynamic genetic tests should be performed during the whole treatment process, which is significantly essential for efficacy evaluation and treatment decision- making.